Date published: 2025-11-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr727 Inhibitors

Olr727 inhibitors are a class of chemical compounds that specifically target the Olr727 receptor, a member of the olfactory receptor family predominantly involved in the detection of specific chemical stimuli. These inhibitors are designed to interact with the Olr727 receptor, altering its normal function in the detection and transduction of olfactory signals. The precise mechanisms by which these inhibitors interact with the Olr727 receptor can vary, but typically involve binding to the receptor's active site or allosteric sites, thereby modulating its activity. This modulation can result in either competitive or non-competitive inhibition, depending on the specific binding interactions and structural characteristics of the inhibitor molecules. The study of Olr727 inhibitors provides significant insights into the structural and functional dynamics of olfactory receptors, contributing to a broader understanding of olfaction at the molecular level.

From a chemical perspective, Olr727 inhibitors can exhibit a diverse range of structures, often characterized by their ability to mimic or block natural ligands of the Olr727 receptor. These compounds can include small organic molecules, peptides, or larger macromolecular structures designed to achieve high specificity and affinity for the receptor. The development and characterization of these inhibitors involve sophisticated techniques such as high-throughput screening, molecular docking, and structure-activity relationship (SAR) studies. Additionally, advanced analytical methods, including X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, are employed to elucidate the binding interactions and conformational changes induced by these inhibitors. The ongoing research in this field not only enhances our understanding of olfactory receptor biology but also provides a foundation for exploring the broader implications of receptor-ligand interactions in sensory perception.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$74.00
$119.00
33
(1)

EGFR inhibitor, potentially disrupting proteins in EGFR signaling pathways.

Anastrozole

120511-73-1sc-217647
10 mg
$90.00
1
(1)

Aromatase inhibitor, potentially affecting estrogen production and related protein pathways.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

Inhibits VEGFR, EGFR, and RET tyrosine kinases, potentially affecting proteins in associated signaling pathways.

Letrozole

112809-51-5sc-204791
sc-204791A
25 mg
50 mg
$85.00
$144.00
5
(1)

Aromatase inhibitor, potentially affecting estrogen production and related protein pathways.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

CDK4/6 inhibitor, potentially impacting proteins involved in cell cycle regulation.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

BCR-ABL tyrosine kinase inhibitor, potentially disrupting proteins in leukemia signaling pathways.

Exemestane

107868-30-4sc-203045
sc-203045A
25 mg
100 mg
$131.00
$403.00
(0)

Aromatase inhibitor, potentially affecting estrogen production and related protein pathways.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$246.00
$490.00
$536.00
16
(1)

JAK1/2 inhibitor, potentially impacting proteins in JAK-STAT signaling pathways.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

RAF kinase inhibitor, potentially affecting proteins in RAF/MEK/ERK signaling pathways.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Multi-kinase inhibitor, potentially affecting proteins in angiogenesis and cell proliferation pathways.